ReviewClinical ophthalmology (Auckland, N.Z.)2023
Transepithelial Photorefractive Keratectomy for Hyperopia Correction: An Uncharted Territory.
Review in Clinical ophthalmology (Auckland, N.Z.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Effectiveness of Lotrafilcon B and Balafilcon A bandage contact lenses on epithelial healing and visual symptoms after transepithelial photorefractive keratectomy in the hyperopic patients.BMC ophthalmology · 2026Trial
- Comparison of visual quality and optical zones after TransPRK, SMILE, and FS-LASIK myopia correction procedures.BMC ophthalmology · 2025Trial
- Clinical features of patients who needed more than one-time photorefractive keratectomy (PRK), a retrospective cohort study.BMC ophthalmology · 2025Article
- The Impact of Preoperative Corneal Epithelial Refraction Toricity on Transepithelial Photorefractive Keratectomy for the Treatment of Hyperopia or Mixed Astigmatism.Vision (Basel, Switzerland) · 2025Article
- Advances in Transepithelial Photorefractive Keratectomy versus Laser-Assisted In Situ Keratomileusis.Diagnostics (Basel, Switzerland) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Transepithelial photorefractive keratectomy (Trans PRK) is a relatively new technology for refractive surgery and has shown promising results in myopia correction. The data on hyperopia correction by this method are limited. In this review, we have attempted to understand the outcomes of this technology on hyperopic eyes. There are comparable results with conventional PRK and laser in situ keratomileusis (LASIK) as far as refractive stability, regression rate, predictability, and post-operative complications are concerned. The best results have been obtained in lower hyperopic corrections. In moderate to higher hyperopia, the limited data available show higher regression, unstable visual outcomes, and increased stromal haze. There is a need to evaluate the technology further to understand its success for hyperopic refractive surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.